NYSE: MSGSMadison Square Garden Sports Corp Stock
$213.96+1.84 (+0.87%)
Updated Jan 13, 2025
MSGS Price
$213.96
Fair Value Price
N/A
Market Cap
$5.13B
52 Week Low
$176.27
52 Week High
$237.99
P/E
73.27x
P/B
-18.5x
P/S
4.83x
PEG
N/A
Dividend Yield
N/A
Revenue
$1.04B
Earnings
$70.05M
Gross Margin
40.1%
Operating Margin
14.63%
Profit Margin
6.8%
Debt to Equity
-5.95
Operating Cash Flow
$120M
Beta
0.77
Next Earnings
Feb 4, 2025
Ex-Dividend
N/A
Next Dividend
N/A
MSGS Overview
Madison Square Garden Sports Corp. operates as a professional sports company. Its portfolio of assets include the New York Knickerbockers of the National Basketball Association (NBA), and the New York Rangers of the National Hockey League; two development league teams, including the Hartford Wolf Pack of the American Hockey League, and the Westchester Knicks of the NBA G League; Knicks Gaming, an esports franchise; and esports teams. The company also owns two professional sports team performance centers, including the Madison Square Garden Training Center in Greenburgh, New York, and the CLG Performance Center in Los Angeles, California. Madison Square Garden Sports Corp. was formerly known as The Madison Square Garden Company. The company was founded in 1879 and is based in New York, New York.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine MSGS's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Value
C
Growth
C
Momentum
B
Sentiment
C
Safety
C
Financials
C
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Be the first to know about important MSGS news, forecast changes, insider trades & much more!
MSGS News
Overview
Due Diligence Score
–
Industry Average (19)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how MSGS scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
MSGS is forecast by analysts to be unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
MSGS is poor value based on its earnings relative to its share price (73.27x), compared to the US market average (29.88x)
P/E vs Market Valuation
MSGS is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more MSGS due diligence checks available for Premium users.
Valuation
MSGS price to earnings (PE)
For valuing profitable companies with steady earnings
Company
73.27x
Industry
26.6x
Market
29.88x
MSGS is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
MSGS is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
MSGS price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-18.5x
Industry
3.22x
MSGS's financial health
Profit margin
Revenue
$53.3M
Net Income
-$7.5M
Profit Margin
-14.1%
MSGS's Earnings (EBIT) of $151.76M... subscribe to Premium to read more.
Interest Coverage Financials
MSGS's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$1.4B
Liabilities
$1.7B
Debt to equity
-5.95
MSGS's short-term liabilities ($574.68M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
MSGS's long-term liabilities ($1.08B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
MSGS's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
MSGS's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$26.2M
Investing
-$1.2M
Financing
-$9.5M
MSGS's operating cash flow ($120.11M)... subscribe to Premium to read more.
Debt Coverage Financials
MSGS vs Entertainment Stocks
Madison Square Garden Sports Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.